Pharmacists in Ontario are about to take on a significantly larger clinical role. In September 2025, the Ontario Ministry of Health announced plans to expand the province's Minor Ailments Program by adding 14 new conditions to the list of ailments that pharmacists can independently assess and prescribe for. The expansion represents one of the most significant shifts in Ontario pharmacy practice in years.
Building on an Existing Foundation
Ontario launched its Minor Ailments Program in January 2023, initially allowing pharmacists to prescribe for 13 common conditions. These included urinary tract infections, allergic rhinitis, oral thrush, dermatitis, acid reflux, hemorrhoids, menstrual cramps, cold sores, impetigo, insect bites, tick bites, sprains and strains, and pink eye.
The program was designed to reduce pressure on emergency departments and walk-in clinics by directing patients with straightforward conditions to their local pharmacy instead. By all accounts, it has been successful. Hundreds of thousands of assessments have been completed, freeing up physician appointments for more complex cases.
The addition of 14 new conditions would nearly double the scope of the program, making pharmacists an even more central point of care for everyday health concerns.
Why Expansion Makes Sense
Ontario faces a well-documented primary care access problem. Approximately 2.3 million Ontarians do not have a family physician. Walk-in clinics are overwhelmed. Emergency departments regularly see patients with non-urgent conditions simply because those patients have no other option.
Pharmacies, by contrast, are everywhere. Ontario has over 4,500 community pharmacies, most with extended hours and no appointment requirements. Expanding the minor ailments program leverages this existing infrastructure to deliver care where patients already go.
From a cost perspective, pharmacist assessments for minor ailments are less expensive than physician visits or emergency department presentations. The Ontario government pays pharmacists a consultation fee for each minor ailment assessment, which is substantially lower than the equivalent billing for a physician visit.
Alberta Sets the Pace
Ontario's expansion is notable, but Alberta remains the national leader in pharmacist prescribing authority. Alberta pharmacists have had prescribing rights since 2006, and the scope of their practice has expanded steadily since then. Alberta pharmacists can prescribe for a wide range of conditions, initiate therapy for chronic diseases, order lab tests, and administer injections.
Alberta has also moved further by allowing pharmacists to operate independent prescribing clinics, separate from traditional pharmacy dispensaries. These clinics function similarly to walk-in medical clinics but are staffed by pharmacists with additional prescribing authorization.
Ontario's program, while growing, still operates within more defined boundaries than Alberta's model. However, each expansion narrows the gap and signals the direction of pharmacy practice across the country.
Public Perception Is Shifting
A Leger survey confirmed what many pharmacists already sense: the public increasingly views pharmacists as healthcare providers capable of more than dispensing medications. Patients who have used minor ailment services report high satisfaction, citing convenience, accessibility, and the quality of care received.
This shift in perception matters. Pharmacy scope expansion requires not only regulatory changes but also public willingness to seek care from pharmacists. As more patients have positive experiences with pharmacist prescribing, demand for these services grows, creating a virtuous cycle that supports further expansion.
Implementation Considerations
Expanding the minor ailments list requires careful planning. Pharmacists need access to updated clinical decision support tools, standardized assessment protocols, and clear referral pathways for cases that exceed the scope of pharmacist prescribing. Documentation systems must capture assessment findings, prescribing decisions, and follow-up plans in a format that can be shared with the patient's broader care team.
Continuing education is also essential. While pharmacists are highly trained clinicians, prescribing for new conditions requires focused preparation. The Ontario College of Pharmacists and pharmacy associations are expected to provide training resources aligned with the expanded scope.
Compensation remains a point of discussion. Pharmacists and pharmacy owners want assurance that the consultation fees for minor ailment assessments adequately reflect the time and expertise involved. Underfunding the program risks undermining its success by creating a disincentive for participation.
The Bigger Picture
Ontario's expansion is part of a national trend. Provinces across Canada are recognizing that pharmacists can safely and effectively manage a broader range of clinical responsibilities. Each expansion of scope demonstrates that pharmacist prescribing improves access without compromising patient safety.
At PlusVirtual, we support every initiative that puts pharmacists closer to the center of patient care. Expanding minor ailment prescribing aligns with our mission to make healthcare more accessible, and we look forward to helping our patients benefit from these changes.